ACRO Biomedical Co., Ltd. (TPEX:6748)
Taiwan · Delayed Price · Currency is TWD 200.00
-21.50 (-9.71%)
Sep 17, 2026, 2:04 PM CST
ACRO Biomedical Market Cap
ACRO Biomedical has a market cap or net worth of 5.19 billion as of September 17, 2026. Its market cap has increased by 16.42% in one year.
Market Cap
5.19B
Enterprise Value
5.09B
Revenue
52.76M
Ranking
n/a
PE Ratio
n/a
Stock Price
200.00
ChartMarket Cap Chart
Since July 27, 2021, ACRO Biomedical's market cap has increased from 990.62M to 5.19B, an increase of 423.75%. That is a compound annual growth rate of 37.99%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 16, 2026 | 15.88B | 292.98% |
| Dec 31, 2025 | 4.04B | 158.32% |
| Dec 31, 2024 | 1.56B | -35.07% |
| Dec 29, 2023 | 2.41B | 135.16% |
| Dec 30, 2022 | 1.02B | 9.09% |
| Dec 30, 2021 | 938.97M | -5.21% |
| Jul 27, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Medigen Vaccine Biologics | 19.63B |
| TaiMed Biologics | 16.28B |
| Ever Supreme Bio Technology | 15.87B |
| Gongwin Biopharm Holdings | 15.20B |
| EirGenix | 14.62B |
| Lumosa Therapeutics | 12.59B |
| AP Biosciences | 10.68B |
| Steminent Biotherapeutics | 10.48B |